Worldwide Human Liver Model Industry to 2027 – Featuring Biopredic International, CN Bio Innovations and NeurOmics Among Others – ResearchAndMarkets.com

Worldwide Human Liver Model Industry to 2027 – Featuring Biopredic International, CN Bio Innovations and NeurOmics Among Others – ResearchAndMarkets.com




Worldwide Human Liver Model Industry to 2027 – Featuring Biopredic International, CN Bio Innovations and NeurOmics Among Others – ResearchAndMarkets.com

DUBLIN–(BUSINESS WIRE)–The “Human Liver Model Market Research Report by Product, by Application, by Region – Global Forecast to 2027 – Cumulative Impact of COVID-19” report has been added to ResearchAndMarkets.com’s offering.

The Global Human Liver Model Market size was estimated at USD 1,624.90 million in 2020, is expected to reach USD 1,812.28 million in 2021, and is projected to grow at a CAGR of 11.89% to reach USD 3,569.37 million by 2027.

Competitive Strategic Window:

The Competitive Strategic Window analyses the competitive landscape in terms of markets, applications, and geographies to help the vendor define an alignment or fit between their capabilities and opportunities for future growth prospects. It describes the optimal or favorable fit for the vendors to adopt successive merger and acquisition strategies, geography expansion, research & development, and new product introduction strategies to execute further business expansion and growth during a forecast period.

FPNV Positioning Matrix:

The FPNV Positioning Matrix evaluates and categorizes the vendors in the Human Liver Model Market based on Business Strategy (Business Growth, Industry Coverage, Financial Viability, and Channel Support) and Product Satisfaction (Value for Money, Ease of Use, Product Features, and Customer Support) that aids businesses in better decision making and understanding the competitive landscape.

Market Share Analysis:

The Market Share Analysis offers the analysis of vendors considering their contribution to the overall market. It provides the idea of its revenue generation into the overall market compared to other vendors in the space. It provides insights into how vendors are performing in terms of revenue generation and customer base compared to others. Knowing market share offers an idea of the size and competitiveness of the vendors for the base year. It reveals the market characteristics in terms of accumulation, fragmentation, dominance, and amalgamation traits.

The report provides insights on the following pointers:

1. Market Penetration: Provides comprehensive information on the market offered by the key players

2. Market Development: Provides in-depth information about lucrative emerging markets and analyze penetration across mature segments of the markets

3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments

4. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players

5. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and breakthrough product developments

The report answers questions such as:

1. What is the market size and forecast of the Global Human Liver Model Market?

2. What are the inhibiting factors and impact of COVID-19 shaping the Global Human Liver Model Market during the forecast period?

3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global Human Liver Model Market?

4. What is the competitive strategic window for opportunities in the Global Human Liver Model Market?

5. What are the technology trends and regulatory frameworks in the Global Human Liver Model Market?

6. What is the market share of the leading vendors in the Global Human Liver Model Market?

7. What modes and strategic moves are considered suitable for entering the Global Human Liver Model Market?

Market Dynamics

Drivers

  • Rising prevalence rate of non-alcoholic fatty liver disease
  • Emerging 3D and 2D trends in modeling human liver disease in vitro
  • Rising initiatives and awareness about liver organoids

Restraints

  • Lack of skilled and trained professionals

Opportunities

  • Growing focus on drug discovery activities
  • Potential growth of healthcare in the Asia Pacific and Latin America

Challenges

  • Generation of complex human organoid models

Companies Mentioned

  • BioIVT LLC
  • Biopredic International
  • CELLINK GLOBAL
  • CN Bio Innovations
  • Cyfuse Biomedical K.K.
  • Emulate Inc.
  • HREL Corporation
  • InSphero AG
  • MIMETAS B.V.
  • NeurOmics, Inc.
  • Organovo Holdings Inc
  • STEMCELL Technologies Inc.
  • Thermo Fisher Scientific Inc.
  • ZenBio, Inc.

For more information about this report visit https://www.researchandmarkets.com/r/72za06

Contacts

ResearchAndMarkets.com

Laura Wood, Senior Press Manager

press@researchandmarkets.com

For E.S.T Office Hours Call 1-917-300-0470

For U.S./CAN Toll Free Call 1-800-526-8630

For GMT Office Hours Call +353-1-416-8900